NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Supriya Gupta
Rush University Medical Center - Chicago / United States
Others
AD Scientific Index ID: 4445562
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Supriya Gupta's MOST POPULAR ARTICLES
1-)
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort studyCOVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ...Anaesthesia 76 (6), 748-758, 20214132021
2-)
The effects of vasopressin on human facial responses related to social communicationR Thompson, S Gupta, K Miller, S Mills, S OrrPsychoneuroendocrinology 29 (1), 35-48, 20042422004
3-)
A comprehensive review on emerging constructed wetland coupled microbial fuel cell technology: potential applications and challengesS Gupta, P Srivastava, SA Patil, AK YadavBioresource Technology 320, 124376, 2021922021
4-)
LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+ P) vs chemotherapy (Chemo) in previously untreated …TB Powles, BP Valderrama, S Gupta, J Bedke, E Kikuchi, ...Annals of Oncology 34, S1340, 20231392023
5-)
Systematic review of the literature: best practicesS Gupta, P Rajiah, EH Middlebrooks, D Baruah, BW Carter, KR Burton, ...Academic radiology 25 (11), 1481-1490, 20181232018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept